Researchers discover new procedure for treatment of uterine fibroids

Jersey Shore University Medical Center announces today that Mark Martens, M.D., chief of Obstetrics and Gynecology, performed the first Acessa procedure in New Jersey. The procedure is used for the treatment of uterine fibroids. Additionally, Jersey Shore's Jocelyn A. Carlo, M.D., Obstetrics/Gynecology, is performing the procedure.

Uterine fibroids are benign growths on the uterus that usually occur during childbearing years. While most fibroids are asymptomatic, some may grow and cause heavy menstruation, painful sexual intercourse, and urinary tract problems. In rare cases, fibroids may complicate pregnancy. As many as 3 out of 4 women have uterine fibroids by the time they reach 50.

The Acessa procedure is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy the fibroids. After treatment, the fibroids are re-absorbed by the surrounding tissue. Acessa allows the doctor to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. More than 300 women have been successfully treated with Acessa.

"We are delighted to introduce patients to the Acessa procedure," says Dr. Martens. "It represents a major breakthrough in the treatment of uterine fibroids—a common and potentially uncomfortable health issue."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Maternal RSV vaccination timing optimizes newborn immunity through improved antibody transfer